|
PERSONAL
INFORMATION
Date of
Birth:
May 18, 1942
Place of
Birth:
Racine, Wisconsin
Spouse:
Bette
Office:
The William Storms Allergy Clinic
1625 Medical Center Point, Suite 190
Colorado Springs, CO 80907
(719) 955-6000 Fax: (719) 955-9595
PRESENT
ACADEMIC RANK & OTHER POSITIONS
Clinical
Professor of Medicine, University of Colorado Health
Sciences Center, Denver, CO
Practicing
Allergist, Asthma & Allergy Associates, P.C., Colorado
Springs, CO
Director of
the Research Center at the William Storms Allergy Clinic,
Colorado Springs, CO
Member of
Sports Medicine Committee of the U.S. Olympic Committee
1997 to present
IRB member,
United States Olympic Committee, 1997 to present
National
Asthma Education and Prevention Program Coordinating
Committee, (NHLBI Asthma Guidelines) 1998 to present
Co-Chair,
Professional and Patient/Public Education Subcommittee of
the NAEPP 1998 to present
Vice-Chair,
Task Force On Allergic Disorders: Promoting Best Practice
1998 to present
EDUCATION
University:
Northwestern University, Evanston, IL
Bachelor of Arts degree, 1964
Medical
School:
University of Wisconsin Medical School, Madison, WI
Doctor of Medicine degree, 1968
Internship:
San Francisco General Hospital, San Francisco, CA, 1968-69
Residency:
Internal Medicine Residency; University of Wisconsin
Hospital
Madison, WI, 1969-70, 1972-73
Fellowship:
Allergy and Immunology University of Wisconsin Hospital,
Madison, WI 1973-75
Private
Practice:
Asthma & Allergy Associates, P.C., Colorado Springs,
CO,
1975 to present
BOARD
CERTIFICATION
American
Board of Internal Medicine, 1974
American
Board of Allergy and Immunology, 1975
Recertification:
American Board of Allergy and Immunology, 1987
MEDICAL
LICENSURE
Colorado #16815
SOCIETY
MEMBERSHIPS
Fellow,
American College of Physicians
Fellow,
American Academy of Allergy, Asthma and Immunology
Fellow,
American College of Allergy, Asthma and Immunology
Fellow,
American College of Chest Physicians
Western
Society of Allergy and Immunology
American
Thoracic Society
Trudeau
Society
Colorado
Allergy Society
American
Association for the Advancement of Science
European
Respiratory Society
Colorado
Medical Society
European
Academy of Allergology and Clinical Immunology
MEMBERSHIP ON
COMMITTEES; OFFICES HELD
Board of
Regents Member, American College of Allergy and
Immunology, 1990 to 1993
President,
Colorado Allergy Society, 1990-92
President,
Western Society of Allergy and Immunology, 1987-88
Chairman,
Public Relations Committee, American College of Allergy
and Immunology, 1988
Chairman,
Bylaws Committee, Penrose Hospital, Colorado Springs, 1985
to 1988
Chairman,
American Academy of Allergy and Immunology Sports Medicine
Committee, 1994-97
Steering
Committee, American College of Chest Physicians Section on
Allergy and Clinical Immunology, 1986-91
El Paso
County Medical Society Delegate to the Colorado Medical
Society, 1989 to 1996
Advisory
Board Member of Strategic Institute, a CME provider,
Vienna, Virginia, 1996 to present
Member of The
Steering Committee of the Aspen Allergy Conference 1997 to
present
MEDICAL
JOURNAL EDITORIAL BOARDS
Associate
Editor of Medicine and Science in Sports and Exercise,
2003 to present
Member of
Editorial Board for Asthma Magazine, 1999 to present
Member of
Editorial Board for Journal of Asthma, 1992 to present
Member of
Editorial Board for American Journal of Medicine and
Sports, 2001 to 2004
Member of
Editorial Board for Pediatric Rounds Newsletter, 1996 to
2000
Member of
Editorial Board for Annals of Allergy, Asthma and
Immunology, 1993 to 1998
Reviewer for
ADIS International, Medical Journals, Journal of Allergy
and Clinical Immunology, Medicine and Science in Sports
and Exercise, Annals of Allergy, Asthma and Immunology,
Annals of Internal Medicine, Chest
OTHER
ACTIVITIES, ORGANIZATIONS, & AWARDS
Distinguished
Fellow of the American College of Allergy, Asthma &
Immunology. Presented atthe awards convocation
November 6, 1998 in Philadelphia, PA.
Bela Schick
invited Lectureship, American College of Allergy, Asthma,
& Immunology, Annual Meeting, San Francisco, November
1994
President,
Cheyenne Mountain Zoological Park, 1991-92
Board of
Trustees Member, 1987 to 1995
Vestry
member, Chapel of Our Saviour Episcopal Church, Colorado
Springs, 1978-81
Listed in
"The Best Doctors in America" 1996 to present
Who's Who in
Health and Medicine, 1989 to present
Student
Volunteer, Project Hope, Colombia, South America, Summer
1967
Vice
President, Broadmoor Ski Racing Academy, Inc., 1979-82
Volunteer
Physician, Colorado Champ Camp (for children with asthma),
1985-95
Certificate
of Appreciation from the Department of Medicine,
University of Colorado School of Medicine for outstanding
contributions to the Department of Medicine, 2000
Career
Achievement Award for Excellence in Teaching Clinical
Research and Medical Literature Contributions in Allergy
and Clinical Immunology from the Department of Medicine of
the University of Colorado School of Medicine 2004
Named one of
the "Best Doctors in America" 1999 to present
Named
"Americas Top Doctors" 2000 to present
PRESENTATIONS
AT NATIONAL & INTERNATIONAL MEETINGS
1.
"Late Adverse Reactions to Alternaria."
Presented at the American Academy of Allergy Meeting,
February, 1974
2.
"Sch 1000 - An Anticholinergic
Bronchodilator." Presented at the American
College of Chest Physicians Meeting, November, 1974
3.
"Procaterol Metered-Dose Inhaler in the Treatment of
Asthma." Presented at the 41st Annual Congress
of the American College of Allergists, February, 1985
4.
"Albuterol Inhalant Solution for Asthma."
Presented at the 41st Annual Congress of the American
College of Allergists, February, 1985
5.
"Ipratropium in the Treatment of Bronchial
Asthma." Presented at the 41st Annual Congress
of the American College of Allergists, Poster Session,
February, 1985
6.
"Azelastine in the Treatment of Asthma."
Presented at the Academy of Allergy and Immunology, Poster
Session, March, 1985
7.
"Albuterol Inhalant Solution." Presented
at the American College of Allergists meeting at the
Schering symposium on New Horizons in Allergy, January 16,
1986
8.
"Safety and Efficacy of Azelastine in Perennial
Allergic Rhinitis." Presented at the American
College of Allergists meeting, February, 1987
9.
"Long-term Treatment of Asthma with Procaterol
Metered-Dose Inhaler: A Two and One-Half Year
Open-Label Study." Presented at the American
College of Chest Physicians 53rd Annual Scientific
Assembly, Poster Session, October 29, 1987
10.
"Variability of Tree Pollination over 5
Years." Presented at the American College of
Allergy and Immunology, November 15, 1987
11.
"SCH 434 (loratadine 5 mg plus pseudoephedrine 120
mg) Versus Components in the Treatment of Seasonal
Allergic Rhinitis." Presented at the
Forty-fourth Annual Meeting of the American Academy of
Allergy and Immunology, March, 1988
12.
"Once-A-Day Triamcinolone Acetonide (TA) Nasal
Aerosol is Effective for Perennial Allergic
Rhinitis." Presented at the Forty Fifth Annual
Convention of the American College of Allergy and
Immunology, November, 1988
13.
"Ipratropium Bromide (Atrovent); Clinical Usage in
Asthma." Presented at a symposium at the 46th
Annual Meeting of the American College of Allergy and
Immunology, November, 1989
14.
"Update on New Advances in the Therapy of Allergic
Rhinitis." Presented at a symposium at the
American College of Allergy and Immunology Meeting,
November, 1990
15.
"Allergic Rhinitis" Washington University
Symposium on Allergic Disease, St. Louis, November 1990
16.
"A Once-A-Day Nasal Steroid (Nasacort - triamcinolone
acetonide) is Effective Therapy for Perennial Allergic
Rhinitis." Presented at the Ninth Annual Aspen
Allergy Conference, July 23-27, 1991, Aspen, Colorado
17.
"New Therapeutic Approaches to Allergic
Rhinitis," American Academy of Allergy and
Immunology, March 1992; Orlando, Florida
18.
"Lipoxygenase and Leukotriene Inhibitors."
Presented at the 1992 American College of Allergy and
Immunology Symposium entitled "A New Age In the
Therapy of Allergic Diseases," November 18, 1992.
19.
"Sch 1000 - An Anticholinergic
Bronchodilator." Presented at the Symposium on
the Parasympathetic Pathway in Obstructive Lung Disease,
Killarney, Ireland, 1974
20.
"Azelastine in Bronchial Asthma."
Presented at the Azelastine Symposium at the International
College of Allergy and Clinical Immunology, Washington,
D.C., October 1985
21.
"Ipratropium in the Treatment of Asthma."
Presented at the Symposium on Cholinergic Pathways in Lung
Disease, Toronto, July 1986
22.
"Bronchodilator Properties of Azelastine."
Azelastine Workshop - American Lung Association Meeting,
New Orleans, May 1987
23.
"Azelastine: U.S. Experience in Seasonal and
Perennial Rhinitis." Presented at the XIVth
Congress of the European Academy of Allergology and
Clinical Immunology, Berlin (West), September 1989
24.
"Effect of Repeat Action Albuterol Sulfate (Proventil Repetabs) in
Nocturnal Asthma," presented at the XIV International
Congress of Allergology and Clinical Immunology, Kyoto,
Japan, October 1991
25.
"The Effect of Repeat Action Albuterol Sulfate
Tablets (Proventil Repetabs) in the
Treatment of Nocturnal Asthma," presented at the
Fifth International Conference on Chronobiology, Amelia
Island, Florida, July 16, 1992
26.
"Rationale for the Use of Antihistamines in Allergic
Rhinitis, " International Symposium of Infection and
Allergy of the Nose, Seoul, Korea, October 8-11, 1993
27.
"Fluticasone Nasal Spray: Comparator Studies in
Allergic Rhinitis," European Academy of Allergy and
Immunology, Stockholm, Sweden, June 1994
28.
Moderator and Discussant, Interesting Case Symposium,
American College of Allergy, Asthma & Immunology,
Annual Meeting, San Francisco, CA, November 1994
29.
Co-Chairman of the Olympic Exercise Asthma Symposium,
Colorado Springs, CO, December 2-4, 1994.
30.
"Diagnosis and Treatment of Asthma."
Lecture at the American Academy of Family
Physicians. Annual Meeting, Orlando, FL, September
1995.
31.
"Exercise Asthma in Athletes." Presented at the
Eastern Allergy Conference, April 18, 1995.
32.
"Long-term budesonide therapy in severe asthma:
A 2 1/2 year open label study." Poster presentation,
Aspen Allergy Conference, July 1995.
30.
"Asthma Quality of Life Surveys in an Office
Setting," ACAAI Managed Care Conference, Washington
DC, April 12, 1996.
31.
Chairman, United States Olympic Committee Conference on
Asthma for Physicians, Coaches and
Athletic Trainers, November 1996, U.S. Olympic Training
Center, Colorado Springs, CO.
32.
Moderator and speaker, ACAAI Annual Meeting Saturday
Morning Conference, San Diego, CA.
33.
Speaker, AAAAI Sunday Evening Symposium on the Treatment
of Asthma, March 1998, Washington DC.
34.
Luncheon moderator "Treatment of Rhinitis and Its
Effects on the Lower Airway", Sunday symposium at the
AAAAI meeting, Washington DC, March 1998.
35.
Speaker on Exercise-Induced Asthma at the 1st Sports
Medicine Conference of the Arab World, Kuwait University,
Kuwait City, Kuwait, March 1998.
36.
Speaker at the International Congress of Pediatric Allergy
& Immunology, Cordoba, Argentina, May 24-27, 1998
("Safety and efficacy of montelukast in children: a
review of clinical data"; "Improving control of
asthma in the moderately severe asthmatic".
37.
"The Profile of the Ideal Nasal Steroid" at the
European Academy of Allergy and Clinical Immunology
Meeting, Brussels, Belgium, July 1999.
38.
"Exercise Induced Asthma", presented at Cornell
Medical College Allergy Teaching Day, New York, NY,
October 1999.
39.
"Asthma and Rhinitis", presented at the American
College of Allergy, Asthma and Immunology Annual Meeting,
Chicago, IL, November 1999.
40.
"Exercise-Induced Asthma", presented at the
American Academy of Allergy, Asthma and Immunology
Meeting, San Diego, CA, March 2000.
41.
"Treatment of Vasomotor Rhinitis: Summary of
Physicians Survey and Double-Blind Study of Azelastine in
Vasomotor Rhinitis", presented at the European
Academy of Allergy and Clinical Immunology, Lisbon,
Portugal, July 2000.
42.
"Treatment of Allergic Rhinitis in Children",
presented at the Weekend of the Nose Meeting, Prague,
January 2001.
43.
Invited Lecturer, "Treatment of Exercise
Asthma", National Association of Athletic Trainers
Annual Meeting, July 2001.
44.
"Therapeutic Options for Nonallergic Rhinitis",
European Academy of Allergy and Clinical Immunology,
Berlin, Germany, May 2001.
45.
"What are the New Third Generation Antihistamines and
What Do They Do", presented at Nose 2000,
International Congress of Rhinology, Washington DC,
September 2000.
46.
"Criteria for the Ideal Nasal Steroid",
presented at the American College of Allergy, Asthma and
Immunology Meeting, Seattle, WA, November 2000.
47.
"Relationship Between Allergic Rhinitis and
Asthma", American Academy of Allergy, Asthma and
Immunology Symposium, March 18, 2001.
48.
"The Relationship of Allergic and Non-allergic
Rhinitis", Allergic Rhinitis Symposium at the
European Academy of Allergy and Clinical Immunology, May
11, 2001.
49.
"Methods of Controlling Rhinitis", Allergic
Rhinitis Symposium; American College of Allergy, Asthma
and Immunology meeting, November 19, 2001.
50.
"Treatment of Allergic Rhinitis and Comorbid
Conditions", Lecture at the Primed South Meeting,
Florida, February 21, 2002.
51.
"Economic and Clinical Impact of Allergic
Rhinitis", AAAAI Meeting, Allergic Rhinitis
Symposium, March 3, 2002.
52.
"Diagnosis and Treatment of Exercise-induced
Asthma", AAAAI Meeting, March 4, 2002.
53.
"The Link Between Allergic Rhinitis and Asthma",
Primed West Meeting, Long Beach, California, April 5,
2002.
54.
"Treatment of Allergic Rhinitis with Specific
Reference to Non-sedating Antihistamines ", Lectures
in Taiwan, April 19 - 21, 2002.
55.
"The Role of Leukotriene Antigonists in the Treatment
of Asthma", Tokyo, Japan, August 31, 2002.
56.
"The Allergic March: The Progression of Allergy From
Infancy to Adulthood", American College of Allergy
and Immunology Meeting, San Antonio, TX, November 14,
2002.
57.
"The Use of Intranasal steroids in the Treatment of
Allergic Rhinitis", Rhinitis Symposium, ACAAI
Meeting, San Antonio, TX, November 17, 2002.
58.
"Clinical Trials: Are These Our Patients?",
American Academy of Allergy and Immunology, Annual
Meeting, Denver, CO, March 2003.
59.
"Allergies and Asthma in Athletes", US Olympic
Committee Conference on the Athens Olympic Games 2004;
Effects of Heat and Humidity, Colorado Springs, CO,
September 2003.
60.
"Exercise-Induced Asthma in Athletes", USA
Cycling Coaches Conference, Colorado Springs, CO, Jan 29,
2004.
CLINICAL
TRIALS PERFORMED AT THE RESEARCH CENTER
Ipratropium
bromide inhaler for the treatment of asthma - various
studies, 1975-1990
Flunisolide
inhaler for the treatment of asthma - 1977
Tazifyline
tablets in rhinitis - 1987
Albuterol
inhalant solution for asthma - 1984
Ketotifen
syrup for children in asthma - 1984-1987
Procaterol
inhaler for asthma - various studies - 1984-1990
Alupent
inhaler for children with asthma - 1985-1989
Triamcinolone
nasal spray for the treatment of rhinitis - various
studies, 1986-1991
Loratadine
and loratadine decongestant tablet studies for the
treatment of rhinitis - 1986 to 1995
Tazifyline
tablets in rhinitis - 1987
Enprofylline
tablets for asthma - 1987
Proventil
Repetabs for asthma - 1987-1989, 1992
Budesonide
inhaler for asthma and rhinitis - 1987, 1991-1995
Efficacy of
azelastine in perennial allergic rhinitis - 1988
Intal MDI for
asthma - 1988
MK 571
capsules for asthma - 1989
Accolate
inhaler and tablet for asthma - 1989-1995
Auranofin
capsules for steroid dependent asthmatics - 1989-1990
Nedocromil
inhalant solution for children with asthma - 1990
Salmeterol
inhaler for asthma - 1990-1995, 1997
SCH 37370
tablet for rhinitis - 1990-91
Azelastine
nasal spray for rhinitis - 1990
Vancenase-AQ
vs. Nasalcrom in allergic rhinitis (pediatric) - 1990
Triamcinolone
nasal spray (Nasacort) in allergic rhinitis
(pediatric) - 1990
Pemirolast -
1991
Oral ebastine
for allergic rhinitis - 1991-1998
Formeterol in
Asthma - 1992
MK-0591 for
asthma - 1992-1993
Vanceril DS -
1992-1993
Zileuton in
Asthma - 1992, 1994, 1997
Fluticasone
in Asthma and Rhinitis Adult and Pediatric - 1992-1995,
1997, 1998, 1999, 2000, 2001
Albuterol
Turbuhaler - 1993
CP-80633
Tablet for Asthma - 1993
RP-73401 in
Asthma - 1993
Uniphyl vs
Beclovent - 1993
Non-CFC
Salbutamol - 1993
MK-0476 in
adults & pediatrics for asthma - 1993-1999
Mometasone in
Asthma and Rhinitis - 1993-1994, 1997-1998, 1999
rhu-IL-IR in
Asthma - 1993-1994
rhu-IL-4R in
Asthma - 1999, 2000, 2001
Ceftibuten in
Sinusitis - 1993-1994
Azelastine in
Asthma - 1993-1995
Cetirizine in
Allergic Rhinitis - 1994, 1997-1998, 2000, 2001
HOE 140 in
Asthma - 1994
Nasacort
Prophylaxis in Allergic Rhinitis - 1994
PDA-641
Capsules in Asthma - 1994-1996
Terfenadine
and Metabolite in Rhinitis - 1994
Non-CFC
Beclomethasone - 1994-1995, 1997-1998
Patient
Compliance with Bronchodilator Therapy in Asthma - 1994
Atrovent in
Allergic Rhinitis - 1994-1995
Effects of
Vancenase on Growth - 1994
M94-216 in
adult asthma - 1995
Non-CFC
Azmacort in adults with asthma - 1995
Accolate in
pediatric patients with asthma - 1995-1998
Accolate in
adults with asthma - 1995-1998
SB205312 in
adults with allergic rhinitis - 1995
SB205312 in
adults with asthma - 1995
SR 27417A in
adults with asthma - 1995-1996
AA 2414 in
adults with asthma - 1995
Budesonide
nebulizing solution - 1995-1996
Atrovent
nasal spray in adults with rhinitis - 1995
Fluticasone
in sinusitis - 1996-present
BAYx7195 in
adults with asthma - 1996
Double-strength
beclomethasone nasal spray in adults with asthma and
rhinitis - 1996
RPR 106541T
in adults with asthma - 1996
D7193 in
adults with asthma - 1996
RG50294 in
adults with rhinitis - 1996
Non-CFC Intal
in exercise-induced asthma - 1997
Fexofenadine
in adults and pediatrics in rhinitis - 1994-1995, 1997,
2000, 2001
Fexofenadine
in adult urticaria - 1996-1997
SB 207499 in
adult COPD - 1997
Serevent in
adult COPD - 1997-1998, 2000, 2001
Raxar in
adult sinusitis - 1997-1998
Tiotropium in
adult asthma - 1997
Norestemizole
in allergic rhinitis - 1997
Zanamavir in
influenza - 1998, 1999, 2000
Seratrodast
in adult COPD - 1997
Seratrodast
in adult asthma - 1996
MK-0966 in
adults with osteoarthritis - 1997-1999, 2000, 2001
MK-0663 in
adults with osteoarthritis - 1998 to present
Salmeterol/fluticasone
in COPD - 1998-1999
Azelastine in
vasomotor rhinitis - 1999
HMR 3647A in
adult sinusitis - 1998-1999
Astra
AR-C68397AA in COPD - 1998-1999, 2000-2001
Fluticasone
versus zafirlukast in asthma - 1998-1999
Salmeterol/fluticasone
in adult asthma - 1998-1999, 2000, 2001
Merck
L-808,065 in adult asthma - 1998-1999
Desloratadine
in adult rhinitis and asthma - 1999, 2000
Montelukast
in adults with rhinitis and asthma - 1999, 2000
Effects of
nasal fluticasone on growth - 1999-2000, 2001
Effects of
Accolate on growth - 1999
Effects of
Azmacort on growth - 1999
Lansoprazole
in adults with asthma and GERD - 1999, 2000
Triamcinolone
effects on growth - 1999-2000
Montelukast
in exercise-induced asthma in adults and pediatrics -
1999-2000, 2001
Accolate in
pediatric exercise-induced asthma - 1999-2000
Effect of
Rhinocort on growth - 1999-2001
Albuterol
metered dose solution in adult asthma 1999-2000
Montelukast
vs beclomethasone on growth - 2000, 2001
Bay 19-8004
in adults with asthma - 2000
Tequin in
adult sinusitis - 2000
Merck
L-753099 in COPD - 2000
IV
montelukast in acute asthma - 2000
Serevent in
adult exercise-induced asthma - 2000-2001
Ciclesonide
in adult and pediatric asthma - 2001
Anapatrilat
in adult hypertension - 2001
Salamol Easi-Breathe
device in adult asthma - 2001
SB207499 in
COPD - 2001
Loteprednol
exabonate nasal spray in adults with rhinitis - 2001
Levalbuterol
nebulized in acute asthma - 2001
Advil
Multi-Symptom Allergy Sinus in adult rhinitis - 2001
Budesonide
aqueous nasal spray (Rhinocort Aqua) in children with PAR
- 2000-2001
Oral
montelukast sodium vs. inhaled fluticasone propionate in
patients with mild persistent asthma - 2000-2002
Montelukast
w/placebo & inhaled beclomethasone in pediatric
patients w/mild asthma - 2000-02
Roflumilast
in patients with asthma - 2001
PLT 3514
dietary supplement in asthmatic children ages 12 -17 years
- 2001
Clinical
effects of montelukast in patients with PAR - 2001-2002
Formoterol
fumarate delivered by multi-dose dry powder inhaler -
2001-2002
Tecastemizole
in subjects with SAR and concomitant asthma - 2001-2002
PLT 3514
dietary supplement in asthmatic children ages 6-11 years -
2001
Fexofenadine
in subjects with PAR - 2002
IN537217
nasal spray in subjects with PAR - 2002
Tecastemizole
in subjects with SAR - 2002
T.I.M.E.
migraine study, Zomig - 2002
Symbicort vs.
its mono-products in children (>6 years) and adults
with asthma - 2002
Symbicort vs.
its mono-products in adolescents (> 12 years) and
adults with asthma - 2002
Levalbuterol
and recemic albuterol - 2002-2003
Etoricoxib
vs. diclofenac sodium in patients with osteoarthritis -
2002 - 2003
Effect of
L-454560 in adult patients with chronic asthma - 2002-2003
Pulmicort
Respules and Pulmicort Turbuhaler in adolescents (12 years
and older) and adults with moderate to severe asthma -
2003
Olopatadine
nasal spray vs. placebo in adolescents and adults with PAR
- 2003
PUBLICATIONS
1.
Chloroform parties, Storms WW, JAMA 225:160-165, July 9,
1973.
2.
Aerosol Sch 1000: an anticholinergic bronchodilator,
Storms W, DoPico G, and Reed CE, Amer Review of Resp Dis,
111:149, April 1975.
3.
Alternaria IgG precipitins and adverse reactions, Busse
WW, Storms WW, Crandal M, and Reed CE, J Allergy Clin
Immunol, 57:367, April 1976.
4.
Antibody-dependent cellular cytotoxicity in asthmatics,
Flaherty DK, Martin JM, Storms WW, Kriz RJ, Surfus JE and
Reed CE, J Allergy Clin Immunol, 59:48-53, 1977.
5.
Occupational hypersensitivity lung disease, Storms WW, J
of Occupational Med, 20:823-824, 1978.
6.
Allergic reactivity of the Pikes Peak region, Storms WW,
Southern Med Journal, 72:673-675, June 1979.
7.
Miller moth asthma, Storms WW, Berry C, and Withee W, Clin
Allergy, 11:55-59, January 1981.
8.
Hay fever symptoms from the cotton of the cottonwood tree,
Storms WW, Ann Allergy, 53:223-225, September 1984.
9.
Albuterol nebulizer solution for the treatment of asthma,
Storms WW, Hudson LD, DeGraff AC, Mendelson LM, Greenstein
S, Ann Allergy, 55:779-782, December 1985.
10.
Ipratropium bromide (Atrovent R ): A new
anticholinergic bronchodilator for the treatment of
asthma, Storms WW, Immunol Allergy Practice, Vol III, P
53-59, February 1986.
11.
Bitolterol mesylate aerosol in adults with
steroid-dependent asthma: A comparison with
isoproterenol hydrochloride aerosol, Nathan RA, Bodman SF,
Storms WW, Mingo TS, Ann Allergy, 56:494-499, June 1986.
12.
Use of ipratropium bromide in asthma: Results of a
multi-clinic study, Storms WW, Bodman SF, Nathan RA, Busse
WW, Bush RK, Falliers CJ, O'Hollaren JD, and Weg JG, Amer
J Med, 81:61-66 (suppl 5A), November 1986.
13.
SCH: 434; A new antihistamine/decongestant for seasonal
allergic rhinitis, Storms WW, Bodman SF, Nathan RA,
Chervinsky P, Banov CH, Dockhorn RJ, Jarmoszuk I, Zeitz HJ,
McGeady SJ, Pinnas JL, Greenstein S, J Allergy Clin
Immunol, June 1989, Vol 83, No.6:1083-1090.
14.
Procaterol metered-dose inhaler: A multiclinic study
evaluating the efficacy and safety in patients with
asthma, Storms WW, Chervinsky P, Bell T, Kemp JP, Brandon
ML, Reed CE, Siegel SC, Repsher L, Ann Allergy,
63:444-448, November 1989.
15.
Evaluation of the safety and efficacy of multiple doses of
Azelastine to adult patients with bronchial asthma over
time, Tinkelman EG, Bucholtz GA, Kemp JP, Koepke JW,
Repsher LH, Spector SL, Storms WW, vanAs A, Am Rev Resp
Dis, 141:569-574, 1990.
16.
Managing Allergic Rhinitis: Implications for the upper and
lower airways, Kaliner MA, Beer DJ, Bone RC, Busse WW,
Creticos PS, Gardiner LJ, Lillington GA, McFadden EF,
Naclerio RM, Storms WW, Nelson HS, Pipkorn U, Raphael GD,
Simons FE, Slavin RG, Toffel PH, Ziemniak JA, J Resp Dis,
March 1991.
17.
Metaproterenol (AlupentTM ) metered-dose inhaler in
children 5-12 years of age, Storms WW, Bierman CW, Chai H,
Dockhorn RJ, Eggleston P, Ellis EF, Feldman C, Fink JN,
Hemstreet MP, Kniker WT, Knutsen A, Konig P, Mansmann H,
Siegell S, Krantman H, Tinkelman D, Townley R, Wecker M,
Jaeger J, J Allergy, 28:369-379, 1991.
18.
The effect of repeat action albuterol sulfate (ProventilR
RepetabsR) in nocturnal asthma, Storms WW, Nathan RA,
Bodman SF, Morris RJ, Selner JC, Greenstein SM, Zwillich
CW, J of Asthma, 29(3):205-212, 1992.
19.
Update on the outpatient treatment of asthma, Storms WW in
Comprehensive Therapy, 18(3):31-36, 1992.
20.
Hay Fever: What it is and what to do about it, Storms WW,
Asthma and Allergy 1992, Healthline, Menlo Park, CA.
21.
Effect of acute inhalation of albuterol on submaximal and
maximal VO2 and blood lactate, Fleck SJ, Lucia A, Storms
WW, Wallach JM, Vint PF, Zimmerman SD, Int J Sports Med,
14(1993):239-243.
22.
Long-term safety of triamcinolone acetonide nasal aerosol
for the treatment of perennial allergic rhinitis, Welch MJ,
Bronsky E, Findlay S, Pearlman D, Southern L, Storms W,
Weakley S, Clin Therapeutics, 16(2),(1994):253-262.
22.
Patient compliance with bronchodilator therapy in asthma,
Storms, WW, Current Therapeutic Research,
55(9),(1994):1038-1046.
23.
The Rationale For The Use of H1-Receptor Antagonists,
Storms, WW, Am J Rhinol 8;(1994):376.
24.
The effects of albuterol on power output in non-asthmatic
athletes, J.T. Lemmer, S.J. Fleck, J.M. Wallach, S. Fox,
E.R. Burke, J.T. Kearney, W.W. Storms, Int J Sports Med,
16(1995):243-249.
25.
Practice parameters for allergy diagnostic testing,
Bernstein IL, Storms WW, Ann Allergy, 75(6): December
(Part 11) 1995.
26.
Corticoid-sparing effect of azelastine in the management
of bronchial asthma, Busse WW, Middleton E, Storms W,
Dockhorn RJ, Chu TJ, Grossman J, Weiler JM, Bronsky EA,
Mansfield LE, Bell TD, Hemsworth GR, Perhach JL, D'Eletto
TA, Dam A. Am J Respir Crit Care Med, 153 (1996):122-127.
27.
Effect of allergy specialist care on the quality of life
in patients with asthma, Storms B, Olden L, Nathan R,
Bodman S. Ann Allergy, 75 (6):December (Part 1) 1995.
28.
Evaluation of the topical versus systemic effects of
triamcinolone acetonide aqueous (TAA) nasal spray in
allergic rhinitis, Storms B, Procaccini RL, Smith JA, J
Allergy Clin Immunol, Vol. 95, No. 1, part 2, pg. 197 (Abst.
223), January 1995.
29.
Prophylactic use of topical triamcinolone acetonide nasal
inhaler in patients with seasonal allergic rhinitis,
Storms W, Bernstein D, LaForce C, Pearlman D, Proud D,
Kagey-Sobotka A, Lim J, Creticos P, J Allergy Clin Immunol,
Vol. 97, No. 1, Part 3, January 1996.
30.
Improving the treatment of nocturnal asthma: Use of an
office questionnaire to identify nocturnal asthma
symptoms, Storms WW, Nathan RA, Bodman SF, Byer B, J of
Asthma 3(33):165-168(1996).
31.
Clinical studies of the efficacy and tolerability of
ebastine 10-20 mg once daily in the treatment of seasonal
allergic rhinitis in the US, Storms WW, Drugs, 52:20-25 (suppl
1), 1996.
32.
Management of sinusitis in the asthmatic patient, Storms
W, Ann Allergy, 77(1):July 1996.
33.
The impact of managed care formularies on the practice of
allergy-immunology, Ann Allergy Asthma Immunol, Vol 77,
No.1:4-5 (1996).
34.
Efficacy of triamcinolone acetonide aerosol nasal inhaler
in children with perennial allergic rhinitis, Storms WW,
Southern DL, et.al, Ped Asthma, All & Immunol, Vol 10,
No.2: 59-64 (1996).
35.
Update on exercise-induced asthma, a report of the Olympic
exercise asthma summit conference, Storms WW, Joyner DM,
Physician & Sports Medicine, Vol 25, No.3: 45-55
(1997).
36.
Quality of life and rhinitic symptoms: results of a
nationwide survey with the SF-36 and RQLQ questionnaires,
Meltzer EO, Nathan RA, Selner JC, Storms W, J Allergy Clin
Immunol, Vol 99:S815-9 (1997).
37.
The effects of salmeterol on power output in non-asthmatic
athletes, McDowell SL, Fleck SJ, Storms WW, J Allergy Clin
Immunol, Vol 99, No.4: 443-449 (1997).
38.
Prevalence of allergic rhinitis in the United States,
Nathan RA, Meltzer EO, Selner JC, Storms W, J Allergy Clin
Immunol, Vol 99, No.6-2: S808-814 (1997).
39.
Allergic rhinitis: the patient’s perspective, Storms W,
Meltzer EO, Nathan RA, Selner JC, J Allergy Clin Immunol,
Vol 99, S825-8 (1997).
40.
The economic impact of allergic rhinitis, Storms W,
Meltzer EO, Nathan RA, Selner JC, J Allergy Clin Immunol,
Vol 99, S820-4 (1997).
41.
Treatment of allergic rhinitis: effects of allergic
rhinitis and antihistamines on performance, Storms WW,
Allergy & Asthma Proc, Vol 18, No. 2: 59-61 (1997).
42.
Efficacy and safety of fexofenadine hydrochloride for
treatment of seasonal allergic rhinitis. Bernstein DI,
Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason
J. Ann Allergy Asthma Immunol, 1997;79:443-8.
43.
Do Asthma medications enhance sports performance in
athletes who do not have asthma? Storms WW.
All Resp Dis Sports Med, Marcel Dekker, New York,
1997;389-398.
44.
A practical approach to the diagnosis and management of
allergic rhinitis. Storms WW. Amer Journal of Integrated
Health Care, Vol 1, No. 2 (Winter):78-87 (1998).
45.
Clinical adverse effects of inhaled corticosteroids:
Results of a questionnaire survey of
asthma
specialists. W Storms, C Theen, Ann Allergy,
80:391-4, May 1998.
46.
Risk-benefit assessment of fluticasone propionate in the
treatment of asthma and allergic rhinitis. W Storms, J
Asthma, 35(4):313-336, 1998.
47.
Effects of the inhaled corticosteroids fluticasone
propionate, triamcinolone acetonide, and flunisolide and
oral prednisone on the hypothalamic-pituitary-adrenal axis
in adult patients with asthma. Sorkness CA, LaForce
C, Storms W, et al, Clin Ther, 1999; 21(2):353-367.
48.
A comprehensive diagnostic approach to upper airway
disease. W Storms, J Allergy Clin Immunol,
1998;101:S361-3.
49.
Ipratropium bromide nasal spray 0.03% and beclomethasone
nasal spray alone and in combination for the treatment of
rhinorrhea in perennial rhinitis. R Dockhorn, D Aaronson,
E Bronsky, P Chervinsky, R Cohen, R Ehtessabian, A Finn, J
Grossman, W Howland, H Kaiser, D Pearlman, J Sublett, P
Ratner, G Settipane, T Sim, W Storms, R Webb, K Drda, C
Wood, Ann Allergy Asthma Immunol, 1999;82:349-359.
50.
Administration of budesonide once daily by means of
Turbuhaler to subjects with stable asthma. E McFadden, T
Casale, T Edwards, J Kemp, J Metzger, H Nelson, W Storms,
M Neidl, J Allergy Clin Immunol 1999;104:46-52.
51.
Exercise-induced asthma: diagnosis and treatment for the
recreational or elite athlete. W Storms, Med Sci Sports
Exerc 31:S33-38, 1999.
52.
Double-blind, placebo-controlled study of single doses of
chlorofluorocarbon (CFC) and CFC-free cromolyn sodium for
exercise-induced bronchoconstriction. W Storms, Current
Therapeutic Res 1999;60(12):629-37.
53.
Atypical symptoms can mask the diagnosis. Exercise-induced
asthma: making the diagnosis. W Storms, J Respir Dis
2000;21(8):491-494.
54.
An idea bearing fruit. J Chapman, L Ford, R Miles, W
Storms, J Winder, Ann Allergy Asthma Immunol,
2000;85:89[editorial].
55.
Patient preference of inhaled nasal corticosteroids. W.
Storms, Allergy and Asthma Proc Vol 22, No 6:S1-3, S27-28,
Nov - Dec 2001.
56.
New Rules for Olympic Athletes who take B2 Agonists: The
IOC is Watching. J Weiler, W Storms, Amer Journal of
Medicine & Sports, Vol IV, No II, March/April 2002.
57.
Rethinking our approach to allergic rhinitis management.
WW Storms, Ann Allergy Asthma Immunol,
2002;88(Suppl):30-35, April 2002.
58.
Allergens in the pathogenesis of asthma potential role of
anti-immunoglobulin E therapy. W Storms, Am J Respir Med
2002; 1 (5):361-368.
59.
Review of exercise-induced asthma. W Storms, Med Sci
Sports Exerc, Vol. 35, No. 9;1464-1470, 2003.
60.
Minimal persistent inflammation, an emerging concept in
the nature and treatment of allergic rhinitis: the
possible role of leukotrienes. W. Storms, Ann Allergy
Asthma Immunol, 2003;91:313-140, August 2003.
61.
Unmet needs in the treatment of allergic asthma: potential
role of novel biologic therapies. W Storms, J Managed Care
Pharm, 2003;9(6):534-43, November/December 2003.
62.
Clinical trials: Are these your patients? W Storms, J
Allergy Clin Immunol 2003;112:S107-11.
63.
White paper on the management of allergic rhinitis and its
impact on asthma: Implications for primary care,
published by the Texas Academy of Family Physicians and
Primary Care Education Group, Austin, TX. March
2004.
BOOK CHAPTERS
1.
Storms WW, "Do asthma medications enhance sports
performance in athletes who do not have asthma?", in
Allergic and Respiratory Diseases in Sports Medicine,
edited by John M. Weiler, Vol. II, 389-398, Marcel Dekker,
New York, 1997.
2.
Storms WW, "Allergies and Sports, in Asthma and
Exercise", in Human Kinetics, edited by Rundell,
Wilber and Lemanske, 2002.
3.
Storms WW, "Allergy Diagnostic Procedures", in
Practical Allergy, edited by Milgrom, Usatine, and Spector,
Mosby, 2001.
4.
Storms WW, "Allergic Rhinitis Caused by Inhalant
Factors", in Conn’s Current Therapy, edited by
Rakel and Bope, 2003.
5.
Storms WW, "Role of allergies in the provocation of
exercise-induced asthma", in Exercise-induced Asthma;
Pathophysiology and Treatment, edited by Rundell, Wilbur
and Lemanske, 2002.
6.
Storms WW, Milgrom EC, "Skin Testing", in
Practical Allergy, edited by Milgrom, Usatine, Tan and
Spector, 2004.
7.
Storms WW, Milgrom EC, "Radioallergosorbent Testing (RAST)",
in Practical Allergy, edited by Milgrom, Usatine, Tan and
Spector, 2004.
PUBLISHED
ABSTRACTS
1.
A Study of atopic dermatitis, adenyl cyclase system and
mitosis, Lee TP, Storms WW, Busse W, Reed CE, J Allergy
Clin Immunol, 53:99, 1974 (abstr.)
2.
Use of flow volume curves with air and helium-oxygen to
evaluate pulmonary function in asthma, Storms WW, Bush R,
and Reed CE, J Allergy Clin Immunol 57:252, 1976 (abstr.)
3.
Intranasal immunization with attenuated live influenza
vaccine in asthma, Storms WW, Dick EC, and Busse WW, J
Allergy Clin Immunol, 58:284, 1976 (abstr.)
4.
Allergenicity of the cotton of the cottonwood tree, Storms
WW, New Eng Allergy Proceedings, Vol. 5:151, Spring 1984 (abstr.)
5.
Azelastine (AZEL) in the treatment of asthma, Storms W,
Middleton E, Dvorin D, Kemp J, Spector S, Newton J, and
Perhach J, J Allergy Clin Immunol, 75:167, January 1985 (abstr.)
6.
Multicenter trial of procaterol aerosol metered-dose
inhaler vs. placebo in patients with asthma, Storms W,
Chervinsky P, Bell T, Brandon M, Reed CE, Repsher L,
Siegel S, and Kemp J, J Allergy and Clin Immunol, 75:161,
January 1985 (abstr.)
7.
Procaterol metered-dose inhaler in the treatment of
asthma, Storms W, Bodman S, Nathan R, Wilson JM, Ann
Allergy, 54:338, April 1985 (abstr.)
8.
Albuterol inhalant solution for asthma, Storms W, Bodman
S, Nathan R, Greenstein S, Ann Allergy, 54:367, April 1985
(abstr.)
9.
A group comparative study of the safety and efficacy of
nedocromil sodium (Tilade) in reversible airways
disease: A preliminary report, VanAS A, Chick TW,
Bodman SF, Storms WW, Nathan RA, Selner JC, Koepke JW,
Townley RG, Bewtra AK, Nair N, Kemp JP, Meltzer EO, Welch
MJ, and Prenner BM, Eur J Respir Dis, 69 (suppl 147):
143-148
10.
Comparison of procaterol and albuterol aerosols in
patients with reversible obstructive airways disease,
Chervinsky P, Beaupre A, Bell T, Bronsky E, Busse W,
Campbell S, Falliers C, Mazza J, Pinnas J, Reed C, Repsher
L, Stalein J, Schoenwetter W, Stevens P, Storms W, and
Tashkin D, J Allergy and Clin Immunol, 79:201, January
1987 (abstr.)
11.
Efficacy of azelastine in perennial allergic rhinitis,
Meltzer E, Storms W, Pierson W, Cummins L, Perhach J, and
Hemsworth G, J Allergy Clin Immunol, 79:205, January 1987
(abstr.)
12.
Efficacy of azelastine (AZ) in perennial allergic
rhinitis, Storms WW, Bodman SF, Nathan RA, Perhach JL, and
Hemsworth GR, Ann Allergy, 58:281, April 1987 (abstr.)
13.
Long-term treatment of asthma with procaterol metered-dose
inhaler: a two and one-half year open label study, Storms
WW, Bodman SF, and Nathan RA, Chest, 92:124S, August 1987
(abstr.)
14.
WHR-5029 (triamcinolone acetonide nasal aerosol) in the
treatment of seasonal ragweed allergic rhinitis (SRAR),
Storms WW, Bodman SF, Nathan RA, Gawchick SM, Rooklin AR,
Gorder JW, and Huber FJ, Ann Allergy, 60:166, February
1988 (abstr.)
15.
Variability of tree pollination over 5 years, Storms WW,
Nathan RA, Burdekin EA, Ann Allergy, 60:158,February 1988
(abstr.)
16.
SCH: 434 (loratadine 5 mg plus pseudoephedrine 120 mg)
versus components in the treatment of seasonal allergic
rhinitis, Storms WW, Bodman SF, Nathan RA, Trochelman L,
Greenstein S, J Allergy Clin Immunol, 18:173, January 1988
(abstr.)
17.
Evaluation of the safety and efficacy of long term use of
multiple doses of Azelastine (AZ) in asthmatics, Tinkelman
D, Bucholtz G, Kemp J, Repsher L, Spector S, Storms W,
VanAs A, Koepke J, J Allergy Clin Immunol, January 1988 (abstr.)
18.
Once-a-day Triamcinolone Acetonide (TA) nasal aerosol is
effective for perennial allergic rhinitis (PAR), Storms
W,Bronsky E, Findlay S, Pearlman D, Rosenbert S, Shapiro
G, Southern L, Tinkelman D, Weakley S, Welch M, Zeitz H,
Garcia J, Wilkinson D, Ann Allergy, 1:239, March 1989 (abstr.)
19.
Azelastine: U.S. experience in seasonal and
perennial rhinitis, Storms W, Hemsworth G, Freitag J, as
published in Allergologie, September 1989 (abstr.)
20.
Procaterol: Longer duration of action than albuterol (salbutamol)
in a three month study, Beaupre A, Bell T, Boulet LP,
Bronsky E, Busse W, Campbell SC, Chervinsky P, Falliers
CJ, Mazza J, Pinnas JL, Tashkin DP, Reed CE, Repsher L,
Schoenwetter W, Stablein J, Stevens P, Storms WW, Chest,
98:111S, August 1990
21.
A comparison of the efficacy and safety of procaterol and
albuterol in reversible obstructive airways disease, Mazza
J, Beaupre A, Bell T, Boulet LP, Bronsky E, Busse W,
Campbell SC, Chervinsky P, Falliers CJ, Pinnas JL, Tashkin
DP, Reed CE, Repsher L, Schoenwetter W, Stablein J,
Stevens P, Storms WW, Chest, 98:111S, August 1990
22.
Inhibition by Aerolized ICI 204,219. LTD receptor agonist,
of allergen-induced bronchoconstriction, Nathan RA, Storms
WW, Bodman SF, Minkwitz MC, Glass M, J Allergy Clin
Immunol, January 1991 (abstr.)
23.
Once daily triamcinolone acetonide nasal spray is
effective for the treatment of perennial allergic
rhinitis, Storms W, Bronsky E, Findlay S, Pearlman D,
Rosenberg S, Shapiro G, Southern L, Tinkelman D, Weakley
S, Welch M, Zeitz H, Wilkinson D, McMahon S, Garcia J, Ann
Allergy 66:329, April 1991
24.
Effect of repeat action albuterol sulfate (ProventilR
RepetabsR ) in nocturnal asthma, Storms W, Morris R,
Selner J, Zwillich C, Greenstein S, Colorado Springs, CO,
Minneapolis, MN, Denver, CO, Hershey, PA, Kenilworth, NJ,
Allergy Immunol News, Supplement 1-1991 (presented at the
XIV International Congress of Allergology and Clinical
Immunology, October 4, 1991) (abstr.)
25.
Comparison of intranasal therapy with beclomethasone
dipropionate (BDP) vs cromolyn sodium (CS) vs placebo (P)
in children with seasonal allergic rhinitis (SAR), Orgel
HA, Meltzer E, Welch M, Banov C, Georgitis J, Morris R,
Pedinoff A, Storms WW, J Allergy Clin Immunol, 89:303,
January 1992 (abstr.)
26.
Efficacy of nedocromil nebulizer solution on asthma
symptoms in children maintained on bronchodilators,
Dockhorn RJ, Bronsky EA, Ginchansky EJ, Kraimer MJ,
Pearlman DS, Ratner PH, Storms WW, Amer Rev Respir Dis,
145:743, April 1992
27.
Azelastine nasal spray - a well controlled trial to assess
its safety and efficacy in seasonal allergic rhinitis
(SAR), Storms W, Grossman J, Pearlman D, Chervinsky P,
Halverson P, Widlitz M, Freitag J, Ann Allergy, 68:108,
January 1992 (abstr.)
28.
Albuterol and ergometry performance, Lucia A, Fleck SJ,
Wallach JM, Vint PF, Storms WW, Zimmerman SD, Medicine
& Science in Sports and Exercise, 24(5), May 1992 (abstr.)
29.
Once-a-day ebastine is effective therapy for seasonal
allergic rhinitis (SAR) in children, Storms WW, Garcia JD,
Tobey RE, et al, J Allergy Clin Immunol, 91:197, January
1993
30.
Nedocromil sodium (NED) 0.5% nebulizer solution improves
asthma symptoms and pulmonary function in children. RJ
Dockhorn, EJ Ginchansky, DS Pearlman, PH Ratner, WW
Storms, Ann Allergy, 72:78, January 1994.
31.
Fluticasone Propionate (FP), Triamcinolone acetonide (TAA)
and Flunisolide (FLN) have similar effects on the HPA
axis. W Storms, WC Howland, CA Sorkness, C LaForce, M
Goldstein, WR Lincourt, PR Rogenes, AE Schaberg, L
Edwards, et al, J Allergy Clin Immunol, 99:S318, January
1997.
32.
Efficacy of Astelin (azelastine) nasal spray in patients
with vasomotor rhinitis. WW Storms, J Matz, P Ratner, J
Allergy Clin Immunol 105:S205, January 2000.
33.
The effect of fluticasone propionate nasal spray as
adjunctive therapy to cefuroxime axetil on the resolution
of radiographic evidence of an acute episode of sinusitis.
W Storms, SD Miller, T Goldberg, D Henry, ST
Goode-Sellers, et al, J Allergy Clin Immunol 105:S206,
January 2000.
|
